NanoViricides, Inc.
(AMEX:NNVC)
$1.15
-0.02 (-1.71%)
At Close: 4:00 PM
NanoViricides Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
NanoViricides Stock Price Today
NanoViricides, Inc. (NNVC) stock declined over -0.86% intraday to trade at $1.15 a share on AMEX. The stock opened with a gain of 1.72% at $1.18 and touched an intraday high of $1.22, falling -0.86% against the last close of $1.16. The NanoViricides, Inc. in stock market went to a low of $1.17 during the session.
NanoViricides Stock Snapshot
$1.16
Prev. Close
13.75 Million
Market Cap
$1.17
Day Low
$1.18
Open
11.7 Million
Number of Shares
$1.22
Day High
N/A
P/E ratio
-0.77
EPS (TTM)
0.59
Cash Flow per Share
N/A
Free Float in %
1.10
Book Value
22046.00
Volume
NanoViricides Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
Employees7.00
Beta1.13
Sales or RevenueN/A
5Y Sales Change0.00%
Fiscal Year EndsJun. 2023
SectorHealthcare
IndustryBiotechnology
About Company
NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.
Peers
Frequently Asked Questions
What is the current NanoViricides, Inc. (NNVC) stock price?
NanoViricides, Inc. (AMEX: NNVC) stock price is $1.15 in the last trading session. During the trading session, NNVC stock reached the peak price of $1.22 while $1.17 was the lowest point it dropped to. The percentage change in NNVC stock occurred in the recent session was -0.86% while the dollar amount for the price change in NNVC stock was -$0.01.
NNVC's industry and sector of operation?
The AMEX listed NNVC is part of Biotechnology industry that operates in the broader Healthcare sector. NanoViricides, Inc. , a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections.
Who are the executives of NNVC?
Dr. Anil R. Diwan Ph.D.
Executive Chairman, Pres, Chief Executive Officer & Sec.
Dr. Anil R. Diwan Ph.D.
Exec. Chairman, Pres, CEO & Sec.
Dr. Anil R. Diwan Ph.D.
Executive Chairman, President, CEO & Secretary
Ms. Meeta R. Vyas B.S., M.B.A., SB, MBA
Chief Financial Officer
How NNVC did perform over past 52-week?
NNVC's closing price is 0.18% higher than its 52-week low of $1.04 where as its distance from 52-week high of $2 is -0.68%.
How many employees does NNVC have?
Number of NNVC employees currently stands at 7.00. NNVC operates from 1 Controls Drive, Shelton, CT 06484, US.
Link for NNVC official website?
Official Website of NNVC is: https://www.nanoviricides.com
How do I contact NNVC?
NNVC could be contacted at phone #203 937 6137 and can also be accessed through its website. NNVC operates from 1 Controls Drive, Shelton, CT 06484, US.
How many shares of NNVC are traded daily?
NNVC stock volume for the day was 22046.00 shares. The average number of NNVC shares traded daily for last 3 months was 37 Thousands.
What is the market cap of NNVC currently?
The market value of NNVC currently stands at $13.75 Million with its latest stock price at $1.15 and 11.7 Million of its shares outstanding.